Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Ludovico

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Life (Basel, Switzerland)|August 28, 2025
CFTR Modulators Counteract F508del CFTR Functional Defects in a Pancreatic Epithelial Model of Cystic FibrosisAlessandra Ludovico, Debora Baroni
International Journal of Molecular Sciences|October 14, 2022
Modulator Combination Improves In Vitro the Microrheological Properties of the Airway Surface Liquid of Cystic Fibrosis Airway EpitheliaAlessandra Ludovico, Oscar Moran, Debora Baroni
International Journal of Molecular Sciences|June 12, 2026
Functional Rescue of CFTR-Dependent Transport in a Pancreatic Ductal Epithelial Cell Model: The Impact of Pharmacological Modulation and InflammationAlessandra Ludovico, Martina Battistini, Debora Baroni
International Journal of Molecular Sciences|February 13, 2026
Cystic Fibrosis of the Pancreas: In Vitro Duct Models for CFTR-Targeted Translational ResearchAlessandra Ludovico, Martina Battistini, Debora Baroni
International Journal of Molecular Sciences|August 26, 2023
Elexacaftor Mediates the Rescue of F508del CFTR Functional Expression Interacting with MSD2Roberta Bongiorno, Alessandra Ludovico, Oscar Moran, et al.
Biomolecules|October 23, 2021
NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic FibrosisChiara Brandas, Alessandra Ludovico, Alice Parodi, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR ProteinDebora Baroni, Naomi Scarano, Alessandra Ludovico, et al.
British Journal of Pharmacology|March 3, 2019
Small molecule-facilitated anion transporters in cells for a novel therapeutic approach to cystic fibrosisMichele Fiore, Claudia Cossu, Valeria Capurro, et al.
International Journal of Molecular Sciences|February 27, 2020
Small Molecule Anion Carriers Correct Abnormal Airway Surface Liquid Properties in Cystic Fibrosis Airway EpitheliaAmbra Gianotti, Valeria Capurro, Livia Delpiano, et al.
Neurology. Genetics|February 3, 2026
Functional Characterization of a De Novo <i>SCN2A</i> Mixed Variant Linked to Early Infantile Developmental and Epileptic EncephalopathyAnna Corradi, Antonella Riva, Bruno Sterlini, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Life (Basel, Switzerland)|August 28, 2025
CFTR Modulators Counteract F508del CFTR Functional Defects in a Pancreatic Epithelial Model of Cystic FibrosisAlessandra Ludovico, Debora Baroni
International Journal of Molecular Sciences|October 14, 2022
Modulator Combination Improves In Vitro the Microrheological Properties of the Airway Surface Liquid of Cystic Fibrosis Airway EpitheliaAlessandra Ludovico, Oscar Moran, Debora Baroni
International Journal of Molecular Sciences|June 12, 2026
Functional Rescue of CFTR-Dependent Transport in a Pancreatic Ductal Epithelial Cell Model: The Impact of Pharmacological Modulation and InflammationAlessandra Ludovico, Martina Battistini, Debora Baroni
International Journal of Molecular Sciences|February 13, 2026
Cystic Fibrosis of the Pancreas: In Vitro Duct Models for CFTR-Targeted Translational ResearchAlessandra Ludovico, Martina Battistini, Debora Baroni
International Journal of Molecular Sciences|August 26, 2023
Elexacaftor Mediates the Rescue of F508del CFTR Functional Expression Interacting with MSD2Roberta Bongiorno, Alessandra Ludovico, Oscar Moran, et al.
Biomolecules|October 23, 2021
NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic FibrosisChiara Brandas, Alessandra Ludovico, Alice Parodi, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR ProteinDebora Baroni, Naomi Scarano, Alessandra Ludovico, et al.
British Journal of Pharmacology|March 3, 2019
Small molecule-facilitated anion transporters in cells for a novel therapeutic approach to cystic fibrosisMichele Fiore, Claudia Cossu, Valeria Capurro, et al.
International Journal of Molecular Sciences|February 27, 2020
Small Molecule Anion Carriers Correct Abnormal Airway Surface Liquid Properties in Cystic Fibrosis Airway EpitheliaAmbra Gianotti, Valeria Capurro, Livia Delpiano, et al.
Neurology. Genetics|February 3, 2026
Functional Characterization of a De Novo <i>SCN2A</i> Mixed Variant Linked to Early Infantile Developmental and Epileptic EncephalopathyAnna Corradi, Antonella Riva, Bruno Sterlini, et al.
Pageof 1